Literature DB >> 7888486

Development of an antifertility vaccine for pets based on active immunization against luteinizing hormone-releasing hormone.

A Ladd1, Y Y Tsong, A M Walfield, R Thau.   

Abstract

Male dogs and cats were immunized against LHRH in order to evaluate the feasibility of an immunological approach to pet contraception. In the first study, dogs were immunized with 100, 500, or 2500 micrograms of LHRH conjugated to tetanus toxoid. A significant decline in serum testosterone (T) levels was observed in all immunized dogs, reaching castration levels in some animals by Week 4 and remaining suppressed in all the immunized dogs through the course of the study. Testicular histology suggested arrest of spermatogenesis (infertility). The effects of "immunological castration" were reversible (study 2): steroidogenesis suppressed by "immunological castration" was restored as antibody titers declined. Effective antibodies were rapidly reinduced in dogs by a single injection of LHRH1-TT. In contrast, the level of antibodies induced in male cats (study 3) was not sufficient for "immunological castration." The conclusion was that active immunization against LHRH could provide a cost-effective, nonsurgical, reversible means to control the fertility of companion animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888486     DOI: 10.1095/biolreprod51.6.1076

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  3 in total

Review 1.  Contraceptive vaccines for the humane control of community cat populations.

Authors:  Julie K Levy
Journal:  Am J Reprod Immunol       Date:  2011-04-19       Impact factor: 3.886

2.  Limb malformations and abnormal sex hormone concentrations in frogs.

Authors:  S A Sower; K L Reed; K J Babbitt
Journal:  Environ Health Perspect       Date:  2000-11       Impact factor: 9.031

Review 3.  Desexing Dogs: A Review of the Current Literature.

Authors:  Silvan R Urfer; Matt Kaeberlein
Journal:  Animals (Basel)       Date:  2019-12-05       Impact factor: 2.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.